Abbott India is currently trading at Rs. 18085.35, up by 224.60 points or 1.26% from its previous closing of Rs. 17860.75 on the BSE.
The scrip opened at Rs. 17549.00 and has touched a high and low of Rs. 18145.35 and Rs. 17400.00 respectively. So far 410 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 23902.30 on 05-Oct-2021 and a 52 week low of Rs. 15525.00 on 07-Feb-2022.
Last one week high and low of the scrip stood at Rs. 18145.35 and Rs. 16390.25 respectively. The current market cap of the company is Rs. 38318.87 crore.
The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 7.74% and 17.27% respectively.
Abbott India has reported a rise of 38.66% in its net profit at Rs 211.41 crore for the quarter ended March 31, 2022 as compared to Rs 152.47 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 1,276.07 crore for Q4FY22 as compared Rs 1,114.74 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore as compared to Rs 690.69 crore for the previous year. Total income of the company increased by 13.79% at Rs 4,996.48 crore for year under review as compared to Rs 4,390.92 crore for year ended March 31, 2021.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1855.00 |
Dr. Reddys Lab | 1262.85 |
Cipla | 1560.70 |
Lupin | 2201.80 |
Zydus Lifesciences | 1003.35 |
View more.. |